Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 8/20 | 0.40 |
| ▸ | CCR6 | P51684 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL440372 | 1.00 | PRKCA (0.40) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL20608590 | 1.00 | PRKCA (0.40) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL812763 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL20608618 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL6897539 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL6897541 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL812328 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL6902252 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL809687 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA | |
| SCHEMBL809615 | 0.98 | PRKCA (0.42) | PRKCACCR6NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | claimed |
| CN-113905612-B | Arthropod control composition | 弗门尼舍有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-11504443-B2 | Odor-modulating agent and odor-modulating method | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2022-11-22 | — | — | US | claimed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| EP-3930461-A1 | ARTHROPOD CONTROLLING COMPOSITION | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| EP-3930460-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| WO-2020239980-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| WO-2020239954-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090557-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-0953562-A1 | Beta, gamma-unsaturated delta-keto esters | Givaudan Roure (International) S.A. (CH) | 1999-11-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | PRKCA 3977/4885CCR6 437/4885NFKB1 4299/4885 |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | AGO2, NOP2, FBL | PRKCA 2811/4885CCR6 2666/4885NFKB1 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.